Benefit of a Live Donor for Patients With Hepatocellular Carcinoma on the Waiting List—Reply

In Reply We thank Zhang et al for their Letter on our article1 on the beneficial intention-to-treat effect of living donor liver transplant (LDLT) when compared with deceased donor liver transplant (DDLT) in the setting of patients with hepatocellular cancer (HCC).